Oct 5, 2025
6
min read
Medically Reviewed
Share
Risk 1: The TGA and Software as a Medical Device (SaMD)
The Therapeutic Goods Administration (TGA) is the watchdog of Australian healthcare safety. A critical and often misunderstood area of regulation is "Software as a Medical Device" (SaMD). Software becomes a medical device if it is intended to be used for the diagnosis, prevention, monitoring, treatment, or alleviation of disease.
The Disconnected Risk
Many standalone AI apps on the market are pushing the boundaries of their capabilities. Some "scribe" tools are now offering diagnostic suggestions or probability scores for conditions based on the consultation audio. If a standalone app suggests a diagnosis directly to a doctor and is not listed on the Australian Register of Therapeutic Goods (ARTG), it is likely operating illegally. Using such a tool exposes the clinic to liability if that unregulated advice contributes to a medical error. Furthermore, disconnected apps often operate as "black boxes" with no transparency regarding their training data or error rates, making it impossible for the clinic to perform due diligence on the "device" they are using.
The Unified Solution
A unified platform like MediQo mitigates this risk by strictly defining its role as Clinical Decision Support (CDS) rather than diagnosis. Under TGA guidance, software that provides recommendations to a health professional is generally not considered a medical device if the health professional can independently verify the basis of the recommendation and does not rely solely on it. MediQo’s Clinical Assistant is designed to support the workflow, not replace the doctor. It structures notes and offers "augmented analysis" aligned with general clinical guidelines, but it forces the "Human in the Loop" to validate every output within the clinical interface. This integration ensures the software remains a tool for the clinician, not a replacement, keeping it on the safe side of SaMD regulations.
Risk 2: APP 8 and Cross-Border Data Disclosure
The Australian Privacy Principles (APPs) are the bedrock of data protection in Australia. APP 8 deals with the cross-border disclosure of personal information. It places the onus on the Australian entity (the medical practice) to ensure that any overseas recipient of data does not breach the APPs.
The Disconnected Risk
This is perhaps the most widespread violation in the current market. Many cheap or free AI scribes are simply "wrappers" for public Large Language Models (LLMs) hosted in the United States or elsewhere. When a doctor records a consult on one of these apps, the voice data—containing highly sensitive health information—is sent offshore for processing. If that data is stored on a US server, it is subject to the US CLOUD Act, potentially allowing foreign government access. Furthermore, if the vendor’s terms of service allow them to use that data to train their public models, the clinic has effectively leaked patient secrets to the world. A clinic using a disconnected app rarely has the leverage to negotiate stringent data processing agreements, leaving them liable for any breach that occurs offshore.
The Unified Solution
MediQo eliminates this risk through Data Sovereignty. The platform is hosted entirely within Australia. All data processing, storage, and encryption occur on Australian soil. This ensures that patient data never leaves the legal jurisdiction and is protected by Australian law. By using an enterprise-grade platform, the clinic ensures compliance with APP 8 without needing to audit the server locations of five different apps.
Expert Tips
"Compliance is often seen as a burden, but in the age of AI, it is your safety harness. The risks of using a free app that sends patient voice data to an overseas server are simply too high—not just for your licence, but for your patients' trust. The TGA and the OAIC are very clear: you are responsible for your tools. The only way to exercise that responsibility is to use a platform that is built here, hosted here, and designed to keep you in the driver's seat. Don't let 'Shadow IT' cast a shadow over your practice's future." — Arash Zohuri, CEO, MediQo
Risk 3: The "Human in the Loop" Failure
Both the TGA and the RACGP emphasise the necessity of the "Human in the Loop." AI should never automate a clinical action without human verification.
The Disconnected Risk
Disconnected tools often break this chain of command due to poor workflow design. For example, a standalone AI receptionist might book an appointment or give advice to a patient without any clinical oversight. Or, a scribe tool might email a referral letter directly to a specialist without the GP reviewing it, simply because the app isn't integrated into the practice’s review workflow. These "automation gaps" create safety risks. If the AI hallucinates—invents a fact—and there is no forced step for the doctor to catch it, the error becomes part of the patient’s reality.
The Unified Solution
A unified platform is architected to enforce the "Human in the Loop." MediQo’s Clinical Assistant generates a draft note, but it cannot finalise it into the PMS until the doctor reviews and signs it. CALLA, the AI telephony module, captures intake data but presents it to the clinical team via History-at-a-Glance for verification. The workflow is designed to compel human oversight. The automation handles the drudgery (typing, booking), but the authority remains strictly with the clinician. This alignment with TGA expectations is a core safety feature of the platform.
Key Takeaways
The explosion of Artificial Intelligence (AI) in the Australian healthcare sector has been nothing short of revolutionary. For General Practitioners (GPs) and Practice Managers drowning in administrative burden, the arrival of AI scribes, chatbots, and automated triage tools feels like a lifeline. Consequently, there has been a rush to adopt these technologies, often in a piecemeal fashion. A doctor might download a transcription app on their phone; a practice manager might sign up for a cheap overseas booking bot. This phenomenon, known as "Shadow IT," sees clinics assembling a patchwork of disconnected tools to solve immediate problems.
However, while these tools may offer short-term convenience, they introduce profound long-term risks. The regulatory environment in Australia is strict, governed by the Therapeutic Goods Administration (TGA) regarding patient safety and the Office of the Australian Information Commissioner (OAIC) regarding privacy. Using disconnected, unvetted, or "wrapper" AI apps can inadvertently place a medical practice in breach of the Therapeutic Goods Act 1989 or the Privacy Act 1988. The consequences range from significant fines to reputational ruin and deregistration.
This article dissects the specific compliance risks associated with disconnected AI tools. It argues that the only way to navigate this regulatory minefield safely is to adopt a unified clinical automation platform. By leveraging a system like MediQo, which is architected for the Australian regulatory landscape with "privacy by design" and "Human in the Loop" principles, clinics can innovate without exposing themselves to existential legal threats.
Share